ABSTRACT
F ebrile seizures occur in 2% to 5% of children between 6 and 60 months of age. A common reason for emergency department (ED) evaluation, 1, 2 febrile seizures are classified as simple or complex based on duration, focality, and recurrence within a 24-hour period. 3 Among patients with simple febrile seizures (SFS), multiple studies have demonstrated that central nervous system (CNS) infections are rare in the postvaccine era. [4] [5] [6] [7] In response, the American Academy of Pediatrics (AAP) published a clinical guideline on SFS in 2011 wherein they recommend a lumbar puncture (LP) only when the history or physical examination is concerning for a CNS infection. The guideline further states that a LP is an option in patients 6 to 12 months of age with an incomplete or unknown immunization status or in patients at any age who have been treated with antibiotics.
In the case of complex febrile seizures (CFS), which account for one-third of all febrile seizures, 9 similar guidelines do not exist. In 1991, however, the Joint Working Group of the Research Unit of the Royal College of Physicians and the British Paediatric Association Commission recommended a LP for all cases of CFS in their guideline on convulsions with fever. 10 Subsequently, in 2003, a British guideline by Armon et al. 11 on all childhood seizures discussed CFS, recommending a LP only in those with signs of meningitis or a 2-hour observation before deciding on LP in those without signs of meningitis. Finally, in 2009, in their recommendations for the management of febrile seizures, the Italian League Against Epilepsy stated that a LP should be considered only in patients with a CFS in whom a CNS infection is suspected. 12 Since the publication of these recommendations, however, several studies have reported that the incidence of CNS infections among patients with CFS is low, and a LP may not routinely be indicated. [13] [14] [15] [16] [17] Yet, in the absence of updated evidence-based guidelines specific to the management of CFS, the evaluation and disposition of these patients remains variable and clinician-dependent. [10] [11] [12] [18] [19] [20] [21] [22] Furthermore, our current understanding of the role of LP relative to the incidence of CNS infections among patients with CFS is limited to single-center studies, largely reflecting data from academic institutions. [10] [11] [12] [18] [19] [20] [21] Thus, the primary objective of this study was to describe national LP practice patterns among academic and nonacademic institutions relative to the incidence of CNS infections among children presenting to the ED with a CFS.
METHODS

Study Design
This was a descriptive epidemiologic analysis of national, all-payer hospital-based ED visit-level data from the Nationwide Emergency Department Sample (NEDS) for 2007 through 2014. 23 NEDS is a publicly available database produced annually by the Healthcare Cost and Utilization Project and funded by the Agency for Healthcare Research and Quality. These databases are compiled from cooperating hospitals and EDs through the state ED and inpatient databases and are specifically designed to provide nationally representative estimates of all hospital-based ED visits in given years. In 2014, 30 states and over 900 hospitals contributed data on ED visits, amounting to approximately 20% of all hospital-based ED visits.
23
The database includes up to 15 International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and Current Procedural Technology (CPT) codes for each ED visit, as well as more than 50 other patient, visit, hospital, and region-level variables. Diagnoses are captured by ICD-9-CM coding and are further characterized by Clinical Classifications Software (CCS), which summarizes ICD-9-CM codes into groups for various conditions. For our study, encounters for CFS were identified with the ICD-9-CM code for CFS (780.32) and different types of infections associated with CFS were reported using CCS groups. Procedures were captured by ICD-9-CM or CPT coding. For our study, LP was identified using ICD-9-CM codes 331, 9001, 9002, 9003, and 9009 and CPT code 62270. Hospitallevel variables, including status as a metropolitan teaching hospital, metropolitan nonteaching hospital, or nonmetropolitan hospital, are also available. Estimates of ED utilization using NEDS have been found to be congruent with results from the National Hospital Ambulatory Medical Care Survey. 24, 25 This study was approved by the Wayne State University Institutional Review Board.
Study Setting and Population
For the study sample, we included ED visits in NEDS between 2007 and 2014 for patients with a principal diagnosis code for CFS. We chose our study year to begin in 2007 because this was the first year that ICD-9-CM allowed for the distinction between SFS and CFS. For the ED visits not resulting in admission, the principal diagnosis code can be interpreted as the primary reason for ED visit. For those resulting in admission, the principal diagnosis code is the primary diagnosis of the resultant hospital stay.
We excluded visits for patients ≥ 6 years of age as this is outside the typical age range for febrile seizures. It was not possible to exclude those younger than 6 months of age, however, because NEDS only records age in years. For our study cohort to include previously healthy children without comorbid conditions, we excluded ED visits where there were associated diagnoses (ICD-9-CM) or procedures (ICD-9-CM or CPT) that placed the patient at higher risk of seizures or CNS infections 26 such as previous seizure disorder, trauma, underlying illnesses associated with seizure, immunocompromising conditions, and neurosurgical interventions including a ventriculoperitoneal shunt. 14, 17 The ICD-9-CM codes for the exclusion criteria were elicited by reviewing CCS diagnosis groups for those that fell within the aforementioned exclusion ACADEMIC EMERGENCY MEDICINE • November 2018, Vol. 25, No. 11 • www.aemj.org criteria. Each relevant CCS was then screened and ICD-9-CM codes that met the exclusion criteria were identified and excluded from the analyses (Table S1 , available as supporting information in the online version of this paper, which is available at http://onlinelibrary.wiley.c om/doi/10.1111/acem.13441/full).
Data Analysis
We identified all ED visits with a principal diagnosis of CFS in patients younger than 6 years of age. We then applied our exclusion criteria to arrive at the final sample for analysis ( Figure 1 ). Results are reported by year and by hospital type (metropolitan teaching hospital or other). Summary statistics were obtained for demographics, LP, associated infection by type and ED disposition.
We report the unweighted number of observations included in the sample (Table S2 , available as supporting information in the online version of this paper, which is available at http://onlinelibrary.wiley.com/ doi/10.1111/acem.13441/full), but subsequently report weighted numerical incidence estimates and percentages or estimates for hospital-based ED visits in the United States, for the rest of the analyses (Tables 1 and 2;  Table S3 -S5 [available as supporting information in the online version of this paper, which is available at http://onlinelibrary.wiley.com/doi/10.1111/acem. 13441/full]; Figures 1-3 ). All analyses were conducted in SAS 9.4 (SAS Institute) and Stata 13 (Stata Corp), and all analyses were performed according to the recommendations from the Agency for Healthcare Research and Quality for weighting and stratification.
27-29 p values and confidence intervals (CIs) were calculated from standard errors adjusted for complex sample design and using Student's t-tests and chi-square tests as appropriate. Comparisons between numerical estimates were done with appropriately adjusted F-statistics. While our research aim was not to test a specific hypothesis, but instead to conduct an exploratory analysis, we did perform a formal power analysis. Based on a projected rate of CNS infection among visits for CFS of 0.7% 17 with a target margin for error = 0.1% and an alpha = 0.05, our required sample size was 26,702. Finally, data on facility charges were also available through the Healthcare Cost and Utilization Project (HCUP) databases; thus, total annual and median charge data were gathered for the admitted versus discharged encounters.
RESULTS
During the study period, 7,361 unweighted ED encounters occurred for CFS. Of these, 6,257 unweighted ED encounters were included in the study (Table S2 ). When extrapolated with the database weights, this represents 28,810 encounters nationwide ( Figure 1) . Weighted values are reported for all of the results presented below.
Epidemiology
In our sample, 44.4% were female and the mean age was 1.39 years (95% CI = 1.36-1.42), with the majority (49.3%) being between 1 and 2 years of age Certain encounters met more than one criterion (Table 1) . Most encounters were paid through Medicaid insurance (53.8%), more so at teaching hospitals than nonteaching hospitals (55.2% vs. 49.1%, p = 0.005). While the household income profile was evenly distributed among the quartiles, encounters for patients in the lowest quartile occurred more often at teaching hospitals (32.6% vs. 22.3%, p ≤ 0.001).
Frequency of LP
Lumbar puncture was performed in 25.8% of encounters for CFS ( Figure 2 , Table S3 ; Rao-Scott statistic 5.84, p < 0.001).
Frequency of CNS and Other Infections
Of 28,810 encounters for CFS, there were 80 (95% CI = 41-112) encounters (0.3%) diagnosed with a CNS infection ( Figure 3 , Table S4 ). CNS infections represented 0.5% of all infections associated with the encounters for CFS. The most common infections associated with CFS were the CCS groups for otitis media (16.8%), upper respiratory infections (15.8%), and viral infections (14.6%). Serious bacterial infections such as sepsis (0.5%), urinary tract infection (2.5%), and pneumonia (3.9%) were uncommon.
ED Disposition and Associated Charges
As reported in Table 1 , over half of the encounters for CFS resulted in admission. Overall, the admission rate decreased from 54.3% in 2007 to 39.4% in 2014 ( Figure 2 ). Teaching hospitals were more likely to admit than nonteaching hospitals (55.2% vs. 37.1%, p < 0.001), but notably the transfer rate was significantly higher at nonteaching hospitals (27.9% vs. 4.6%, p < 0.001). The discharge rate was slightly higher at teaching hospitals (39.6% vs. 33.9%, p = 0.04). For discharged patients, the median charge for the encounter was $3,081 and the total annual charge for all encounters was $5.8 million, whereas for admitted patients, the median charge was $10,733 and the total annual charge was $25 million (Table S5) .
DISCUSSION
To our knowledge, this is the largest study to date describing the frequency of LP and CNS infections among pediatric patients presenting to the ED with CFS. In our study, LP was performed in 25.8% of the encounters for CFS, while the incidence of CNS infections among these encounters was very low at 0.3%. Among pediatric CNS infections, acute bacterial meningitis (ABM) garners the most attention due to its associated morbidity and mortality. 30 Fortunately, the incidence of ABM among children in the United States has decreased dramatically since the introduction of the Haemophilus influenzae type b (Hib) vaccine in 1987 31 and the heptavalent pneumococcal conjugate vaccine (PCV7) in 2000. 32 For instance, Adams et al. 31 showed that from 1985 to 1991, following the introduction of the Hib vaccine, the rate of ABM decreased by 82% in children less than 5 years of age. Similarly, Hsu et al. 32 showed that with the introduction of the PCV7 vaccine in 2000, the rates of pneumococcal meningitis decreased by 30% across all age groups. Among children under 2 years of age, the impact of vaccination was more substantial as the incidence of pneumococcal meningitis decreased by 64%. 32 Consequently, in the current postvaccination era, in the setting of CFS, the incidence of ABM ranges from 0% to 1.5%. [13] [14] [15] [16] [17] Importantly, the use of ICD-9-CM diagnostic codes does limit conclusions regarding the specific rate of ABM within the category of CNS infections in our sample. However, our results are very similar to the incidence of ABM reported in the only other large multicentered study published on this topic, 17 suggesting that the rate of CNS infections, which includes the diagnosis of ABM, among patients with CFS is extremely low.
Although ABM is uncommon among patients with CFS, it remains an important diagnosis due to its associated sequelae. 30 In fact, prior to routine universal vaccination, LP was performed in 65% to 96% of patients presenting with CFS due to the concern that CFS was associated with ABM. 19, 33, 34 Subsequent studies that included otherwise healthy children presenting with CFS in the postvaccination era have reported, however, that patients ultimately diagnosed with ABM tend to be less than 12 months of age with altered mental status and an abnormal physical examination consistent with ABM. 13, 14, 17, 35 Thus, while a LP may be warranted in a small subset of patients based on their clinical presentation, our results show that approximately one-quarter of patients nationally are evaluated with a LP. Most notably, this rate does not differ based on hospital teaching status. Although we have noted a temporal decline in LP among patients with CFS, the low yield in the absence of clinical signs of a CNS infection suggests that this procedure need only be performed in specific clinical circumstances.
On those rare occasions where ABM does occur in the setting of CFS, the most common etiology is Streptococcus pneumoniae, which remains the most common cause of ABM among children in the post-Hib vaccine era. 36 Guedj et al. 17 reported that four of five cases of ABM were due to S. pneumoniae and group B Neisseria meningitidis was the pathogen in one case.
Similarly, Kimia et al. 14 reported that the cerebrospinal fluid (CSF) cultures were positive for S. pneumoniae in two of three patients, while in one patient with a negative CSF culture, the blood culture was positive for S. pneumoniae. Immunization status was not specified for the five cases of ABM reported by Guedj et al., 17 but two of the three cases reported by Kimia et al. 14 had incomplete pneumococcal vaccination. Thus, our data coupled with previous studies suggest that a LP in the setting of CFS should only be considered in certain instances based on age, clinical presentation, and immunization status.
As the role of routine LP in patients with CFS has been called into question, [13] [14] [15] [16] [17] the need for inpatient admission has also come under scrutiny. 37 The Joint Working Group of the Research Unit of the Royal College of Physicians and the British Paediatric Association Commission, as well as the Italian League Against Epilepsy, favor hospital admission following a CFS 10, 12 and historically, admission rates ranged from 47% to 71%. [13] [14] [15] 17 Similarly, in our sample, 50% of the encounters resulted in an admission. Teaching institutions had a slightly higher admission rate of 55%. While teaching institutions in our study were more likely to admit than nonteaching institutions, the latter had a significantly higher rate of transfer, likely reflecting transitions to a higher level of care. While we are unable to elucidate the specific reasons for the admission for the encounters in our sample, the high transfer and admission rates may result in part from the need to observe patients and obtain an electroencephalogram (EEG), as recommended by the Italian League Against Epilepsy. 12 Olson et al. 37 recently investigated the utility of this practice, however, and found that while 57% of patients with CFS were admitted, seizure recurrence during admission was uncommon, occurring in 3.8% of patients, and an EEG led to a change in practice for a single patient. While the reasons for admission following a CFS are likely multifactorial, the recommendation to admit for observation 10, 12 warrants further evaluation as high hospital occupancy continues to challenge the health care system. [38] [39] [40] As spending within the United States health care system continues to be a major concern, 41 it is also interesting to note that the associated charges reported in NEDS increased fourfold for admitted patients compared to those discharged from the ED, with the largest financial burden falling upon academic institutions caring for a larger number of publicly insured patients. 42 Administrative charges may not be an adequate substitute for cost, 43 but at a charge of over $25 million annually (Table S5) , evidence-based recommendations regarding the ED evaluation and disposition of these patients are needed.
Overall, our results, coupled with the current literature, suggest that the clinical practice guideline for SFS may be applied to patients with CFS. 8 Thus, LP should only be performed if the history or examination is concerning for a CNS infection. A LP should be considered if 1) there is an incomplete or unknown vaccination status or if 2) the patient has been treated with antibiotics. Prospective studies would be required, however, to validate its application to patients with CFS with attention to its utility among patients with varying seizure semiology (e.g., focal vs. prolonged).
LIMITATIONS
The results of this study must be interpreted in light of some important limitations. First, the NEDS database records patient age in years; thus, it was not possible to set the lower age limit at 6 months for inclusion in the study. As a result, our population may have included patients under 6 months of age, outside of the commonly accepted age range that defines CFS. 1, 2 Second, the records in the NEDS database are based on ED encounters and not patients. If a patient was seen at an ED participating in NEDS and was discharged, but then presented to a second ED participating in NEDS, the patient would have two recorded encounters in NEDS for one illness course. However, NEDS reports that such repeat encounters consist of less than 1.5% of data and are therefore unlikely to have significantly affected our study findings. 23 It is also possible that the discharged patient might have returned to a second ED not participating in NEDS, which would impact our overall estimates of both the rate of LP and CNS infections. However, given that our results reflect previously reported findings, [13] [14] [15] [16] [17] it is unlikely that our study underreported the incidence of CNS infections.
Third, there are inherent limitations associated with relying on administrative claims data. Administrative data are collected for nonresearch purposes; thus, inherent limitations include poor generalizability, a lack of certain clinical patient-level information, and coding that may fulfill billing requirements but not relate faithfully to clinical diagnoses. 43, 44 As a result, in our study, it is possible that our sample does not reflect previously healthy children even though we excluded all patients with diagnostic codes associated with an increased risk of CNS infections or seizures. We were also unable to evaluate the clinical presentation of patients who had a LP performed as well as those ultimately diagnosed with a CNS infection. LP may have been warranted in certain encounters based on the clinical presentation or the immunization status, the latter of which we were also unable to capture using administrative data. Furthermore, we were unable to obtain clinical information to further classify the 1.5% of patient encounters with the diagnosis of "other," without the infection site specified, some of which could have potentially been CNS infections. Finally, since the incidence of CNS infections was so low in our sample and HCUP precludes reporting less than 10 cells worth of data, 23 we were unable to individually characterize the pathogen categories as viral versus bacterial for the unweighted cases with CNS infections, which were less than 10 in our sample.
CONCLUSION
Among previously healthy children presenting to the ED with a complex febrile seizures, one-quarter are evaluated with a lumbar puncture yet very few are diagnosed with a central nervous system infection. The national approach to the evaluation and management of these patients does not reflect our current understanding of the epidemiology, risk factors for, and clinical presentation of central nervous system infections among patients with complex febrile seizures. Thus, there is a need to develop and prospectively validate a clinical practice guideline for children with complex febrile seizures in an effort to optimize the care of these patients.
